Sandbox: T cell: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
Long latency, virus exposure usually occurs very early in life
Long latency, virus exposure usually occurs very early in life
Transmission of HTLV-1 is believed to occur from mother to child; by sexual contact; and through exposure to contaminated blood, either through blood transfusion or sharing of contaminated needles
Transmission of HTLV-1 is believed to occur from mother to child; by sexual contact; and through exposure to contaminated blood, either through blood transfusion or sharing of contaminated needles
 
HTLV-I p40 tax viral protein: non structural protein that causes transcriptional activation of many genes in infected lymphocytes
Enhancement of c-AMP response element binding transcription factor (CREB) phosphorylation
HTLV-I basic leucine zipper factor (HBZ): causes T cell proliferation and oncogenesis
JAK/STAT pathway constitutively activated in HTLV-I infected cells


The disease manifests in 75% of cases with leukaemia and in the remaining as a pure lymphomatous form
The disease manifests in 75% of cases with leukaemia and in the remaining as a pure lymphomatous form
widely disseminated disease which may involve liver, skin, blood stream, bone
widely disseminated disease which may involve liver, skin dermis layer, peripheral blood involvement , bone, and CNS
anaemia and thrombocytopenia is variable
anaemia and thrombocytopenia is variable
patchy infiltrates Bone marrow infiltration
Neutrophilia and eosinophilia Present
Neutrophilia and eosinophilia Present
lytic bone lesions
lytic bone lesions
tumor-induced osteolysis hypercalcaemia
tumor-induced osteolysis hypercalcaemia
increased osteoclastic activity
elevated serum levels of IL-1, TGFβ, PTHrP, macrophage inflammatory protein (MIP-1α), and receptor activator of nuclear factor-κB ligand (RANKL) have been associated with hypercalcemia
elevated serum levels of IL-1, TGFβ, PTHrP, macrophage inflammatory protein (MIP-1α), and receptor activator of nuclear factor-κB ligand (RANKL) have been associated with hypercalcemia


Line 16: Line 23:
Infiltration of the dermis skin infiltration, epidermotropism present and Pautrier's microabcesses
Infiltration of the dermis skin infiltration, epidermotropism present and Pautrier's microabcesses
antibodies to HTLV‐I are demonstrable
antibodies to HTLV‐I are demonstrable
defects of cell-mediated immunity recurrent infections   
defects of cell-mediated immunity recurrent infections
 
 
   
+3, +7, +21, monosomy X,deletion of chromosome Y and chromosomes 6 and 14q;
+3, +7, +21, monosomy X,deletion of chromosome Y and chromosomes 6 and 14q;
14q11 and  break points e TCR‐alpha and ‐delta chain genes TCRA and TCRD
14q11 and  break points e TCR‐alpha and ‐delta chain genes TCRA and TCRD
Line 22: Line 32:
mutations of tumour‐suppressor genes CDKN2A (p16), CDKN2B (p15) and TP53 (p53)
mutations of tumour‐suppressor genes CDKN2A (p16), CDKN2B (p15) and TP53 (p53)


Gross
Nodules skin




Line 29: Line 41:
cytoplasm agranular  
cytoplasm agranular  
“flower cell”
“flower cell”
Reed-Sternberg like cells may also be present


CD4 positive CD8 positive
CD4 positive CD8 positive

Revision as of 13:06, 3 November 2015

Adult T‐cell leukaemia/lymphoma (ATLL) is a mature T‐cell neoplasm of post‐thymic lymphocytes Etiologically linked to the human T‐cell lymphotropic virus, HTLV‐I, HTLV‐I serology is a mandatory investigation Long latency, virus exposure usually occurs very early in life Transmission of HTLV-1 is believed to occur from mother to child; by sexual contact; and through exposure to contaminated blood, either through blood transfusion or sharing of contaminated needles HTLV-I p40 tax viral protein: non structural protein that causes transcriptional activation of many genes in infected lymphocytes Enhancement of c-AMP response element binding transcription factor (CREB) phosphorylation HTLV-I basic leucine zipper factor (HBZ): causes T cell proliferation and oncogenesis JAK/STAT pathway constitutively activated in HTLV-I infected cells

The disease manifests in 75% of cases with leukaemia and in the remaining as a pure lymphomatous form widely disseminated disease which may involve liver, skin dermis layer, peripheral blood involvement , bone, and CNS anaemia and thrombocytopenia is variable patchy infiltrates Bone marrow infiltration Neutrophilia and eosinophilia Present


lytic bone lesions tumor-induced osteolysis hypercalcaemia increased osteoclastic activity elevated serum levels of IL-1, TGFβ, PTHrP, macrophage inflammatory protein (MIP-1α), and receptor activator of nuclear factor-κB ligand (RANKL) have been associated with hypercalcemia

Diffuse infiltration of the lymph node leading expansion of the paracortical area Infiltration of the dermis skin infiltration, epidermotropism present and Pautrier's microabcesses antibodies to HTLV‐I are demonstrable defects of cell-mediated immunity recurrent infections


+3, +7, +21, monosomy X,deletion of chromosome Y and chromosomes 6 and 14q; 14q11 and break points e TCR‐alpha and ‐delta chain genes TCRA and TCRD 14q32 of TCL1 mutations of tumour‐suppressor genes CDKN2A (p16), CDKN2B (p15) and TP53 (p53)

Gross Nodules skin


pleomorphic, a medium size lymphocyte conndensed chromatin convoluted or polylobated nucleus nucleoli are not visibl cytoplasm agranular “flower cell” Reed-Sternberg like cells may also be present


CD4 positive CD8 positive CD2 and CD5 positive CD7 negativ CD3 and T‐cell receptor (TCR)‐β may be down‐regulated